Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Mar 5;15(7):392–397. doi: 10.1016/j.clml.2015.02.021

Table 1.

Baseline patient characteristics (n = 13).

Gender, n (%)
    Male 9 (69.2%)
    Female 4 (30.8%)
Age (years)
    Mean (Std. Dev.) 65.8 (9.99)
    Median (Range) 67.0 (45-83)
Race, n (%)
    Asian 5 (38.5%)
    Black or African-American 1 (7.7%)
    White or Caucasian 7 (53.8%)
Disease Status at Enrollment, n (%)
    Relapsed 10 (76.9%)
    Refractory 3 (23.1%)
ECOG Performance Status, n (%)
    0 8 (61.5%)
    1 4 (30.8%)
    2 1 (7.7%)
Prior Therapies, n (%)
    Chemotherapy 13 (100.0%)
    Radiotherapy 4 (30.8%)
    HCT 0
Prior Lines of Chemotherapy
    Median (Interquartile Range) 4 (3-10)

Abbreviations: ECOG = Eastern Cooperative Oncology Group; HCT = hematopoietic cell transplantation; Std. Dev. = standard deviation.